Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure? Authors' replyAnthony Buisson
Clinics and Research in Hepatology and Gastroenterology|November 6, 2025
Adherent-invasive E. coli (AIEC) in Crohn's disease: where are we in 2025? Tribute to Professor Nicolas BarnichAnthony Buisson, Jérémy Denizot
The Lancet. Gastroenterology & Hepatology|April 11, 2024
Has the time come for a systematic top-down approach in Crohn's disease?Mathurin Fumery, Anthony Buisson
The Lancet. Gastroenterology & Hepatology|December 17, 2023
Guselkumab in Crohn's disease: the IL-23 race continuesMathurin Fumery, Anthony Buisson
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 18, 2011
Haematopoietic stem cell autotransplantation for refractory Crohn's disease: ready for prime time?Anthony Buisson, Laurent Peyrin-Biroulet
The American Journal of Gastroenterology|April 3, 2026
Response to Shen et alYannick Hoffert, Anthony Buisson, Erwin Dreesen
Therapeutic Advances in Gastroenterology|October 3, 2025
Systematic review and network meta-analysis comparing the efficacy of conventional therapy and biologics to prevent endoscopic postoperative recurrence in patients with Crohn's diseaseMarianne Hupé, Bruno Pereira, Anthony Buisson
Gastroenterology|August 27, 2014
An uncommon complication of chronic antibiotics refractory pouchitis after ileal pouch-anal anastomosis for ulcerative colitisFelix Goutorbe, Anthony Buisson, Gilles Bommelaer
Critical Reviews in Microbiology|January 10, 2026
Chitin and its derivatives as potential candidates to reduce intestinal colonization of Crohn's disease-associated adherent and invasive E. <i>coli</i>Margot Fargeas, Devon Kavanaugh, Anthony Buisson
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2025
Author's reply: "Navigating anti-TNF therapy risks: Real-world insights on pregnancy, breastfeeding, and vaccines in IBD patients"Pauline Wils, Marion Simon, Anthony Buisson
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
Alimentary Pharmacology & Therapeutics|February 23, 2023
Editorial: real-world evidence of tofacitinib and vedolizumab in ulcerative colitis-are we one step closer to better positioning therapies after anti-TNF failure? Authors' replyAnthony Buisson
Clinics and Research in Hepatology and Gastroenterology|November 6, 2025
Adherent-invasive E. coli (AIEC) in Crohn's disease: where are we in 2025? Tribute to Professor Nicolas BarnichAnthony Buisson, Jérémy Denizot
The Lancet. Gastroenterology & Hepatology|April 11, 2024
Has the time come for a systematic top-down approach in Crohn's disease?Mathurin Fumery, Anthony Buisson
The Lancet. Gastroenterology & Hepatology|December 17, 2023
Guselkumab in Crohn's disease: the IL-23 race continuesMathurin Fumery, Anthony Buisson
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 18, 2011
Haematopoietic stem cell autotransplantation for refractory Crohn's disease: ready for prime time?Anthony Buisson, Laurent Peyrin-Biroulet
The American Journal of Gastroenterology|April 3, 2026
Response to Shen et alYannick Hoffert, Anthony Buisson, Erwin Dreesen
Therapeutic Advances in Gastroenterology|October 3, 2025
Systematic review and network meta-analysis comparing the efficacy of conventional therapy and biologics to prevent endoscopic postoperative recurrence in patients with Crohn's diseaseMarianne Hupé, Bruno Pereira, Anthony Buisson
Gastroenterology|August 27, 2014
An uncommon complication of chronic antibiotics refractory pouchitis after ileal pouch-anal anastomosis for ulcerative colitisFelix Goutorbe, Anthony Buisson, Gilles Bommelaer
Critical Reviews in Microbiology|January 10, 2026
Chitin and its derivatives as potential candidates to reduce intestinal colonization of Crohn's disease-associated adherent and invasive E. <i>coli</i>Margot Fargeas, Devon Kavanaugh, Anthony Buisson
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2025
Author's reply: "Navigating anti-TNF therapy risks: Real-world insights on pregnancy, breastfeeding, and vaccines in IBD patients"Pauline Wils, Marion Simon, Anthony Buisson
Pageof 17